Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study

• Published in: Obesity surgery 2020-12, Vol.30 (12), p.4852-4859
• Main Authors: Aliakbarian, Hassan, Bhutta, Hina Y., Heshmati, Keyvan, Unes Kunju, Shebna, Sheu, Eric G., Tavakkoli, Ali
• Format: Article
• Language: English
• Subjects: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastrointestinal surgery; Glucagon; Humans; Medicine; Medicine & Public Health; Middle Aged; Obesity, Morbid - surgery; Original Contributions; Patients; Prospective Studies; Surgery; Weight Gain; Weight Loss
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1007/s11695-020-04877-7

Background There are currently few pre-operative predictors of initial and long-term weight loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient characteristics and baseline gut and adipose-derived hormones in predicting maximal total body weight loss (WL max ) and risk of weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery. Methods One hundred five adult patients undergoing primary RYGB were prospectively recruited. Baseline demographics were recorded and fasting plasma glucose, glycosylated hemoglobin (A1C), insulin, glucagon, leptin, active ghrelin, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) levels were measured on day of surgery. Results Our cohort had a mean age of 44.4 ± 13.0 years, and initial BMI (body mass index) of 45.1 ± 6.7 kg/m 2 with mean post-operative follow-up of 40 months. Eighty patients were female and 26 had type 2 diabetes mellitus (T2D). Average WL max was 35.3 ± 7.4%. On univariate analysis, higher baseline fasting ghrelin, lower age, lower CRP (C-reactive protein), lower A1C, and negative T2D status were associated with greater WL max ( p